Indefinite Delivery Contract SPE2DU25D9356

The U.S. Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal government agencies. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

This IDC is part of the DLA Troop Support Medical Supply Chain's upcoming Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple regional prime vendor contracts valued at an estimated $30.3 billion to provide worldwide pharmaceutical support to various DoD customers, including the United States Coast Guard, Designated Providers, and Other Government Agencies. The solicitation for this unrestricted, fully competitive acquisition is expected to be issued in March 2024, with awards made on a regional basis to at least three different contractors based on the lowest overall distribution fee.